INTRODUCTION
In a recent article in the Veterinary Annual, Rweyemamu et al. (6) review ed foot and mouth disease (FMD) control strategies on a world wide basis and discussed factors which affect the control of FMD by vaccination. In this communication it is only intended to highlight those features which may be of special significance to Nigeria.
ZOO-SANITARY MEASURES
FMD control is dependent on effective application of zoo-sanitary measu res as well as effective vaccination programmes. The objectives of FMD zoosanitary regulations are threefold :
1. Prevention of virus entry into the country or district.
Limitation of virus spread if disease should be encountered.
3. Elimination of the virus from the environment as speedily as practica ble.
In practice, in FMD endemic zones like West Africa, successful applica tion of zoo-sanitary measures requires that effective systems should be evol ved and practised strictly in relation to the control of all animal movements from outside and within the FMD control zone. Controlled systematic prophylactic vaccination should also be practised. In the face of an outbreak, immediate quarantine of the infected foci should be enforced coupled with ring vaccination covering a wide perimeter around the infected premise(s), which should never be less than 5 miles. It is essential to be able to confirm every outbreak by laboratory serotyping of the virus.
In Africa an example of strict application of zoo-sanitary measures in support of a vaccination programme is best illustrated by the FMD control programme in Botswana (3). The country is divided into 4 zones by fencing. Movement of cattle from one zone to the next is strictly controlled including physical inspection of each animal. In Kenya it was possible to create a zone in central Kenya which was for long periods free of FMD as a result of synchronised vaccination and strict control of animal movement in and out of the zone (1). However, with the recent expansion of the control zone, an increase in multiple and relatively uncontrollable trade stock movement and uneven vaccination cover have all contributed to a reduction in the apparent effectiveness of FMD control as assessed by outbreak incidences. The burden of FMD control in Kenya seems to have shifted towards exclusive dependence on vaccination. Nevertheless all recent economic analyses have found a favourable cost : benefit ratio in support of FMD control and consequently the area covered by the FMD vaccination programme has progressively been expanded every 2-3 years (2).
THE VACCINE FACTOR
It is evident that an important component in any FMD programme is the availability of potent vaccines. Current commercial vaccines are tested in the country of manufacture and must be shown to meet the standards defined by the European Pharmacopoeia or the British Veterinary Codex before their release for sale. Nevertheless, performance of a vaccine under field condi tions is not merely a function of the quality of the vaccine at the time of its release by the manufacturer. It depends on several factors such as :
1. its potency at the time of vaccination in the field; 2. the antigenic relationship between the vaccine virus and field viruses; 3. the vaccination regimen and the interval between revaccination and disease incidence; Previous studies at the Wellcome Laboratory, Pirbright had shown that Nigerian SAT 1 and SAT 2 virus isolates were serologically different from virus strains currently used for producing vaccines for Eastern and Southern Africa (Tables I and II) . Such vaccines, therefore, would be expected to pro voke a suboptimal response against Nigerian field virus isolates. (3 to 6) .
With the recent declared interest of the Federal Government to initiate a foot and mouth disease control programme it became essential to establish first and foremost whether it is possible to produce potent vaccines from Nigerian virus strains or those virus strains previously shown to be appro priate for Nigeria. The second consideration was whether such commercial vaccines would produce a satisfactory immune response in Nigerian cattle and the third was whether a suitable regime could be evolved. SAT 1 Nig 4/81 and SAT 2 Nig 6/81 virus strains were successfully adapted to rapid growth in BHK suspension cells at the industrial scale. The potency characte ristics of the commercial bivalent SAT 1/SAT 2 vaccine so produced are summarized in Table III . A field study was carried out with a commercially produced vaccine using cattle kept at the National Veterinary Research Institute, Vom. The study was designed to include the effect on vaccine response of age, breed, intercur rent vaccination against CBPP and to determine a suitable vaccination regi men.
Groups of Holstein-Friesian cattle aged from 6 to 12 months, 1 to 2 years and over 3 years were vaccinated with bivalent SAT 1 /SAT 2 vaccine admi nistered either as an initial single vaccination at day 0 only or as an initial course of two injections at 21 days interval with some animals receiving boos ter vaccinations at 120 days post vaccination (dpv). One group of 1-2 years old Holstein-Friesian cattle and a group of Fulani cattle aged over 2 years were vaccinated with vaccine against CBPP at day 0 in addition to receiving FMD vaccine at the same time and 21 days later (Table IV) . All the cattle were bled at intervals up to day 180 and sera were stored at -20°C until transported to the Wellcome Laboratories, Pirbright where they were assayed for neutrali- 
two vaccine viruses using a microneutralization cytopathic effect test employing IBRS-2 cells (4).
The results of serological assay show that all the Nigerian cattle respon ded well to both vaccine viruses (Table V) . The young cattle responded parti cularly well, with Fulani cattle responding as well as the Friesian breed (Figu res 1 and 2) and simultaneous vaccination against CBPP provoked no adverse effect on FMD vaccine response (Table V) .
The cattle in this study had previously been exposed to infection with SAT 1 virus, which left cattle over one year of age with residual titres of over 2 log 10 SN 50 at day 0. This age group gave a typical anamnestic response to vac cination with the SAT 1 component with titres reaching over 3 log 10 SN 50 by 21dpv ( Figure 1 ) and maintaining in the region of 2.5 log10 180 days later. Not all calves aged between 6 and 12 months had these residual antibody titres at the commencement of the study however, and these showed a typical primary response to vaccination with titres over 2.5 log ]0 at 21dpv which were maintained at over 1.5 log 10 and 1.25 log 10 at 120 and 180dpv, respectively. An initial course of two injections improved the duration of response to over 2.0 log I0 at both 120 and 180dpv (Figure 1) . The primary response to vaccina tion with the SAT 2 component was between 1.5 and 2.4 log I0 at 21dpv, depending on the animal groups, and titres were maintained in the region of 1 to 1.5 log 10 up to 180dpv. An initial course of two injections improved this response, particularly in young cattle where titres peaked over 2.5 log ]0 and were maintained between 1.25-1.5 log 10 at 180dpv (Figure 2 ). Revaccination at 120 days improved responses in all cases (Figures 1 and 2 ).
DISCUSSION AND CONCLUSIONS
It has been demonstrated that potent vaccines can be produced on the commercial scale, employing SAT 1 and SAT 2 virus strains isolated from the field in Nigeria. The vaccines maintained their potency during transport from their point of manufacture in the U.K. until they were administered to cattle in Nigeria.
Nigeria cattle responded satisfactorily to vaccination, irrespective of age, breed, or simultaneous vaccination with CBPP vaccine and, in the case of SAT 1, prior exposure to FMD. The response provoked in cattle vaccinated for the first time was shown to be improved by administering the vaccine as an initial course of two injections at 21 day intervals as advised in the manufacturer's 'Directions for Use'.
The antibody profile provoked in the field study indicated that protection of Nigerian cattle could best be achieved by adopting the following regimens, the choice of which is dependent upon the vaccination policies applied by the Federal authorities. a) Primary vaccination should optimally be applied as a course of two injections administered at 21 day interval.
b) Revaccination at 6 monthly intervals will adequately protect the bovine population, provided that the control policy is for blanket vaccination of all cattle on an extended zonal or national basis, together with adequate zoosanitary measures including movement controls. c) If FMD control policy is to rely on the routine vaccination of selected isolated herds or farms then it would be prudent to revaccinate the stock at 4 monthly intervals in order to maintain a high level of immunity.
Regardless of the vaccination regimen adopted it will be necessary to revaccinate all stock at risk immediately should an outbreak of disease occur. Furthermore, vaccination programmes should be scheduled so that both primovaccinates and previously vaccinated stock receive vaccinations within 1 month of the time of greatest challenge expectancy. This would mean, in particular, revaccination of all stock prior to the expected annual animal migrations into Nigeria from the Sahel. 
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